BIOX vs CTVA

For growth investors, Corteva, Inc.

(CTVA) is the stronger pick with 2. 9% revenue growth year-over-year, versus -28. 3% for Bioceres Crop Solutions Corp. (BIOX). Corteva, Inc. (CTVA) offers the better valuation at 49. 4x trailing P/E (21. 6x forward), making it the more compelling value choice. Analysts rate Corteva, Inc. (CTVA) a "Buy" — based on 37 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, Corteva, Inc.

(CTVA) delivered a total return of +68. 3%, compared to -96. 8% for Bioceres Crop Solutions Corp. (BIOX). Over 10 years, the gap is even starker: CTVA returned +186. 7% versus BIOX's -95. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Corteva, Inc.

(CTVA) is the lower-risk stock at 0. 29β versus Bioceres Crop Solutions Corp. 's 1. 94β — meaning BIOX is approximately 560% more volatile than CTVA relative to the S&P 500. On balance sheet safety, Corteva, Inc. (CTVA) carries a lower debt/equity ratio of 11% versus 94% for Bioceres Crop Solutions Corp. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Corteva, Inc.

(CTVA) is pulling ahead at 2. 9% versus -28. 3% for Bioceres Crop Solutions Corp. (BIOX). On earnings-per-share growth, the picture is similar: Corteva, Inc. grew EPS 23. 1% year-over-year, compared to -1704. 7% for Bioceres Crop Solutions Corp.. Over a 3-year CAGR, BIOX leads at 0. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Corteva, Inc.

(CTVA) is the more profitable company, earning 6. 3% net margin versus -15. 5% for Bioceres Crop Solutions Corp. — meaning it keeps 6. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CTVA leads at 15. 1% versus -1. 1% for BIOX. At the gross margin level — before operating expenses — CTVA leads at 43. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

In this comparison, CTVA (0.

9% yield) pays a dividend. BIOX does not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Corteva, Inc.

(CTVA) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 29), 0. 9% yield, +186. 7% 10Y return). Bioceres Crop Solutions Corp. (BIOX) carries a higher beta of 1. 94 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (CTVA: +186. 7%, BIOX: -95. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Basic Materials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

CTVA pays a dividend while BIOX does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.